About Divergent protein kinase domain 1B
Divergent protein kinase domain 1B (DIPK1B) is a protein
from Homo sapiens identified by UniProt accession
Q5VUD6, 431 residues long.
MolForge cross-references it against 0 known binders and
17 disease associations.
Target properties
| Protein name | Divergent protein kinase domain 1B |
| UniProt accession | Q5VUD6 |
| Gene | DIPK1B |
| Organism | Homo sapiens |
| Length | 431 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (17)
Diseases linked to this target (Open Targets).
- body height · score 0.28
- appendicular lean mass · score 0.26
- wheezing · score 0.22
- sitting height measurement · score 0.21
- mean corpuscular hemoglobin · score 0.03
- diastolic blood pressure · score 0.03
- systolic blood pressure · score 0.03
- neurofibrillary tangles measurement · score 0.02
- reticulocyte measurement · score 0.02
- Alzheimer disease · score 0.01
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5VUD6-F1 | alphafold | PREDICTED | 83.18 | — |
Amino-acid sequence (431 residues)
MRRLRRLAHL VLFCPFSKRL QGRLPGLRVR CIFLAWLGVF AGSWLVYVHY SSYSERCRGH VCQVVICDQY RKGIISGSVC QDLCELHMVE WRTCLSVAPG QQVYSGLWRD KDVTIKCGIE ETLDSKARSD AAPRRELVLF DKPTRGTSIK EFREMTLSFL KANLGDLPSL PALVGQVLLM ADFNKDNRVS LAEAKSVWAL LQRNEFLLLL SLQEKEHASR LLGYCGDLYL TEGVPHGAWH AAALPPLLRP LLPPALQGAL QQWLGPAWPW RAKIAIGLLE FVEELFHGSY GTFYMCETTL ANVGYTATYD FKMADLQQVA PEATVRRFLQ GRRCEHSTDC TYGRDCRAPC DRLMRQCKGD LIQPNLAKVC ALLRGYLLPG APADLREELG TQLRTCTTLS GLASQVEAHH SLVLSHLKTL LWKKISNTKY S
Explore Divergent protein kinase domain 1B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets